Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

EYEN

Eyenovia (EYEN)

Eyenovia Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EYEN
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
15/11/202422h57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
13/11/202412h00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EYENEyenovia Inc
12/11/202423h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EYENEyenovia Inc
12/11/202422h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
09/10/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EYENEyenovia Inc
01/10/202423h12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:EYENEyenovia Inc
30/09/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
30/09/202412h24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EYENEyenovia Inc
20/09/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
03/09/202414h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
03/09/202414h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
03/09/202413h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
29/08/202402h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
27/08/202419h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
23/08/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
22/08/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
21/08/202423h25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EYENEyenovia Inc
21/08/202403h18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EYENEyenovia Inc
14/08/202420h50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EYENEyenovia Inc
13/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
07/08/202414h00PR Newswire (US)Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United StatesNASDAQ:EYENEyenovia Inc
29/07/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
19/07/202401h46Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:EYENEyenovia Inc
14/06/202421h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
14/06/202421h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
14/06/202421h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
14/06/202414h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
04/06/202413h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
16/05/202423h04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EYENEyenovia Inc
 Showing the most relevant articles for your search:NASDAQ:EYEN